PH31682A - 4-Iminoquinolines, process for their preparation, and their use. - Google Patents

4-Iminoquinolines, process for their preparation, and their use.

Info

Publication number
PH31682A
PH31682A PH46420A PH46420A PH31682A PH 31682 A PH31682 A PH 31682A PH 46420 A PH46420 A PH 46420A PH 46420 A PH46420 A PH 46420A PH 31682 A PH31682 A PH 31682A
Authority
PH
Philippines
Prior art keywords
iminoquinolines
preparation
image
formula
substituents
Prior art date
Application number
PH46420A
Other languages
English (en)
Inventor
Billhardt-Troughton Uta-Maria
Rosner Manfred
Bender Rudolf
Meichner Christoph
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH31682A publication Critical patent/PH31682A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
PH46420A 1992-06-27 1993-06-25 4-Iminoquinolines, process for their preparation, and their use. PH31682A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221210 1992-06-27

Publications (1)

Publication Number Publication Date
PH31682A true PH31682A (en) 1999-01-18

Family

ID=6462017

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46420A PH31682A (en) 1992-06-27 1993-06-25 4-Iminoquinolines, process for their preparation, and their use.

Country Status (19)

Country Link
US (1) US5602146A (ja)
EP (1) EP0579968B1 (ja)
JP (1) JP3605123B2 (ja)
KR (1) KR940005577A (ja)
CN (1) CN1083477A (ja)
AT (1) ATE184003T1 (ja)
AU (1) AU670435B2 (ja)
CA (1) CA2099213C (ja)
DE (1) DE59309756D1 (ja)
DK (1) DK0579968T3 (ja)
ES (1) ES2136628T3 (ja)
GR (1) GR3031853T3 (ja)
HU (1) HUT70040A (ja)
IL (1) IL106147A (ja)
MX (1) MX9303843A (ja)
NZ (1) NZ247993A (ja)
PH (1) PH31682A (ja)
TW (1) TW304945B (ja)
ZA (1) ZA934576B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4428932A1 (de) * 1994-08-16 1996-02-22 Hoechst Ag Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
US20040157804A1 (en) * 2002-10-16 2004-08-12 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
JP2007532665A (ja) * 2004-04-14 2007-11-15 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖインテグラーゼ阻害剤化合物のホスホネート類似物
EP2116527A4 (en) * 2007-01-23 2011-09-14 Fujifilm Corp OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, METHOD FOR MANUFACTURING THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
JP6483382B2 (ja) * 2014-09-16 2019-03-13 株式会社Adeka 感光性樹脂組成物、その硬化物
JP6734416B2 (ja) * 2019-02-13 2020-08-05 株式会社Adeka 新規化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US758568A (en) * 1903-05-29 1904-04-26 William E Snediker Wrench.
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
US4985439A (en) * 1985-11-21 1991-01-15 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
AU6728687A (en) * 1985-11-21 1987-07-01 Anheuser-Busch Companies Inc. Glucose tolerance factor and method of making same
US5192768A (en) 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
ATE205837T1 (de) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
KR940005577A (ko) 1994-03-21
CA2099213C (en) 2005-11-29
ZA934576B (en) 1994-01-31
ATE184003T1 (de) 1999-09-15
EP0579968A1 (de) 1994-01-26
AU670435B2 (en) 1996-07-18
JP3605123B2 (ja) 2004-12-22
IL106147A (en) 1997-06-10
AU4149293A (en) 1994-01-06
CN1083477A (zh) 1994-03-09
ES2136628T3 (es) 1999-12-01
HU9301875D0 (en) 1993-09-28
DE59309756D1 (de) 1999-10-07
EP0579968B1 (de) 1999-09-01
JPH0673012A (ja) 1994-03-15
MX9303843A (es) 1994-01-31
GR3031853T3 (en) 2000-02-29
HUT70040A (en) 1995-09-28
IL106147A0 (en) 1993-10-20
NZ247993A (en) 1995-11-27
TW304945B (ja) 1997-05-11
CA2099213A1 (en) 1993-12-28
US5602146A (en) 1997-02-11
DK0579968T3 (da) 2000-03-27

Similar Documents

Publication Publication Date Title
ZA937081B (en) Azaquinoxalines processes for their preparation and their use
HK1011971A1 (en) Quinoxalines, process for their preparation and their use
PH30118A (en) Phenylsulfonylamide pyrimidine
ES8401037A1 (es) "procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina".
PH31682A (en) 4-Iminoquinolines, process for their preparation, and their use.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
GR74782B (ja)
GR850955B (ja)
IL95608A0 (en) 1-methoxypyrimidinyl-n-nitro-phenyl-1h,1,2,4-triazole-3-sulphonamide derivatives and herbicidal compositions containing the same
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
PH24990A (en) 1-(1 aryl-2-hydroxyethyl)-imidazoles and salts thereof
PL312966A1 (en) Derivatives of thiocarbamoil
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ZA874596B (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3-heteroaryl-(thio)ureas
MY115291A (en) New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides